Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Goerdt

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 22, 2000
Alternative versus classical activation of macrophagesS Goerdt, O Politz, K Schledzewski, et al.
The Journal of Pathology|February 17, 2006
Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesisK Schledzewski, M Falkowski, G Moldenhauer, et al.
Dermatology (Basel, Switzerland)|August 10, 2005
Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphomaN Poenitz, J Simon-Ackermann, A Gratchev, et al.
The British Journal of Dermatology|April 20, 2012
Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cellsM Felcht, M Heck, C Weiss, et al.
Leukemia|March 25, 2006
Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomasC-D Klemke, B Fritzsching, B Franz, et al.
The British Journal of Dermatology|July 15, 2017
Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patientsY Teramoto, U Keim, A Gesierich, et al.
Leukemia|November 23, 2007
Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3N Booken, A Gratchev, J Utikal, et al.
The Journal of Pathology|January 28, 2006
Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasisJ-H Martens, J Kzhyshkowska, M Falkowski-Hansen, et al.
Experimental Dermatology|September 2, 2024
Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patientsS Melchers, M Roemer, J D Albrecht, et al.
The British Journal of Dermatology|April 14, 2015
Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 casesC D Klemke, N Booken, C Weiss, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 22, 2000
Alternative versus classical activation of macrophagesS Goerdt, O Politz, K Schledzewski, et al.
The Journal of Pathology|February 17, 2006
Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesisK Schledzewski, M Falkowski, G Moldenhauer, et al.
Dermatology (Basel, Switzerland)|August 10, 2005
Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphomaN Poenitz, J Simon-Ackermann, A Gratchev, et al.
The British Journal of Dermatology|April 20, 2012
Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cellsM Felcht, M Heck, C Weiss, et al.
Leukemia|March 25, 2006
Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomasC-D Klemke, B Fritzsching, B Franz, et al.
The British Journal of Dermatology|July 15, 2017
Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patientsY Teramoto, U Keim, A Gesierich, et al.
Leukemia|November 23, 2007
Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3N Booken, A Gratchev, J Utikal, et al.
The Journal of Pathology|January 28, 2006
Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasisJ-H Martens, J Kzhyshkowska, M Falkowski-Hansen, et al.
Experimental Dermatology|September 2, 2024
Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patientsS Melchers, M Roemer, J D Albrecht, et al.
The British Journal of Dermatology|April 14, 2015
Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 casesC D Klemke, N Booken, C Weiss, et al.
Pageof 14